Seasoned investor and operational executive focused on healthcare and technology growth-stage companies. Timothy Caffrey brings experience in corporate development, private equity and venture investing, sourcing deals and scaling commercial operations for portfolio firms. They have led M&A, strategic partnerships and capital raises, and often sits on board committees guiding go-to-market and reimbursement strategies. Known for cross-functional leadership spanning finance, business development and product commercialization, they are a pragmatic value creator for sponsors and limited partners seeking growth-with-governance exposure.
Seasoned investor and operational executive focused on healthcare and technology growth-stage companies. Timothy Caffrey brings experience in corporate development, private equity and venture investing, sourcing deals and scaling commercial operations for portfolio firms. They have led M&A, strategic partnerships and capital raises, and often sits on board committees guiding go-to-market and reimbursement strategies. Known for cross-functional leadership spanning finance, business development and product commercialization, they are a pragmatic value creator for sponsors and limited partners seeking growth-with-governance exposure.
Seasoned investor and operational executive focused on healthcare and technology growth-stage companies. Timothy Caffrey brings experience in corporate development, private equity and venture investing, sourcing deals and scaling commercial operations for portfolio firms. They have led M&A, strategic partnerships and capital raises, and often sits on board committees guiding go-to-market and reimbursement strategies. Known for cross-functional leadership spanning finance, business development and product commercialization, they are a pragmatic value creator for sponsors and limited partners seeking growth-with-governance exposure.
Seasoned investor and operational executive focused on healthcare and technology growth-stage companies. Timothy Caffrey brings experience in corporate development, private equity and venture investing, sourcing deals and scaling commercial operations for portfolio firms. They have led M&A, strategic partnerships and capital raises, and often sits on board committees guiding go-to-market and reimbursement strategies. Known for cross-functional leadership spanning finance, business development and product commercialization, they are a pragmatic value creator for sponsors and limited partners seeking growth-with-governance exposure.
| Trades 175 | Longs Won 91/175 52% | Profit Factor 1.19 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $531,192.39 |
| Average Win $275,918.66 | Best Trade (Mar 31) $2.37M | Sharpe Ratio -803.93 |
| Average Loss -$251,729.05 | Worst Trade (Dec 30) -$3.93M | Z-Score 1.08 (72.18%) |
| Commissions $0 | Avg. Trade Length 9m 2w 5d | Expectancy $22,647.76 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | - | - | - | - | - | - | - | - | - | - |
| Consecutive Losing Trades | 530 | 477 | 424 | 371 | 318 | 265 | 212 | 159 | 106 | 53 |